Abstract

Collisions of the transcription and replication machineries on the same DNA strand can pose a significant threat to genomic stability. These collisions occur in part due to the formation of RNA-DNA hybrids termed R-loops, in which a newly transcribed RNA molecule hybridizes with the DNA template strand. This study investigated the role of RAD52, a known DNA repair factor, in preventing collisions by directing R-loop formation and resolution. We show that RAD52 deficiency increases R-loop accumulation, exacerbating collisions and resulting in elevated DNA damage. Furthermore, RAD52’s ability to interact with the transcription machinery, coupled with its capacity to facilitate R-loop dissolution, highlights its role in preventing collisions. Lastly, we provide evidence of an increased mutational burden from double-strand breaks at conserved R-loop sites in human tumor samples, which is increased in tumors with low RAD52 expression. In summary, this study underscores the importance of RAD52 in orchestrating the balance between replication and transcription processes to prevent collisions and maintain genome stability.

Collisions of transcription and replication machineries on the same DNA strand threaten genomic stability. Here, the authors show that RAD52 prevents these collisions by regulating R-loop formation and resolution. RAD52 deficiency leads to increased R-loops, exacerbated collisions, DNA damage, and higher mutational burden in tumors.

Details

Title
RAD52 resolves transcription-replication conflicts to mitigate R-loop induced genome instability
Author
Jalan, Manisha 1   VIAFID ORCID Logo  ; Sharma, Aman 1   VIAFID ORCID Logo  ; Pei, Xin 1   VIAFID ORCID Logo  ; Weinhold, Nils 1 ; Buechelmaier, Erika S. 1 ; Zhu, Yingjie 2   VIAFID ORCID Logo  ; Ahmed-Seghir, Sana 1 ; Ratnakumar, Abhirami 1 ; Di Bona, Melody 3   VIAFID ORCID Logo  ; McDermott, Niamh 1 ; Gomez-Aguilar, Joan 1 ; Anderson, Kyrie S. 1 ; Ng, Charlotte K. Y. 4 ; Selenica, Pier 2 ; Bakhoum, Samuel F. 3 ; Reis-Filho, Jorge S. 5 ; Riaz, Nadeem 1   VIAFID ORCID Logo  ; Powell, Simon N. 6   VIAFID ORCID Logo 

 MSKCC, Department of Radiation Oncology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 MSKCC, Department of Pathology and Laboratory Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 MSKCC, Department of Radiation Oncology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); MSKCC, Human Oncology and Pathogenesis, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 University of Bern, Department for BioMedical Research, Bern, Switzerland (GRID:grid.5734.5) (ISNI:0000 0001 0726 5157); Swiss Institute of Bioinformatics, SIB, Lausanne, Switzerland (GRID:grid.419765.8) (ISNI:0000 0001 2223 3006) 
 MSKCC, Department of Pathology and Laboratory Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); AstraZeneca, Gaithersburg, USA (GRID:grid.418152.b) (ISNI:0000 0004 0543 9493) 
 MSKCC, Department of Radiation Oncology, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); MSKCC, Molecular Biology Program, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
Pages
7776
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3101006130
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.